Baker Ellis Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Hold |
14,988
| – | – | 0.2% | 88 |
|
|
2026
Q1 | $1.8M | Hold |
14,988
| – | – | 0.21% | 86 |
|
|
2025
Q4 | $1.58M | Sell |
14,988
-749
| -5% | -$70.3K | 0.19% | 87 |
|
|
2025
Q3 | $1.32M | Buy |
15,737
+2,649
| +20% | +$218K | 0.16% | 100 |
|
|
2025
Q2 | $1.04M | Sell |
13,088
-180
| -1% | -$14.3K | 0.14% | 102 |
|
|
2025
Q1 | $1.19M | Buy |
13,268
+340
| +3% | +$31.7K | 0.17% | 96 |
|
|
2024
Q4 | $1.29M | Buy |
12,928
+840
| +7% | +$86.6K | 0.19% | 87 |
|
|
2024
Q3 | $1.37M | Buy |
12,088
+683
| +6% | +$81.1K | 0.19% | 90 |
|
|
2024
Q2 | $1.41M | Buy |
11,405
+400
| +4% | +$51.5K | 0.21% | 85 |
|
|
2024
Q1 | $1.45M | Buy |
11,005
+1,140
| +12% | +$141K | 0.22% | 88 |
|
|
2023
Q4 | $1.08M | Sell |
9,865
-500
| -5% | -$51.9K | 0.17% | 104 |
|
|
2023
Q3 | $1.07M | Sell |
10,365
-300
| -3% | -$32.3K | 0.19% | 96 |
|
|
2023
Q2 | $1.23M | Hold |
10,665
| – | – | 0.21% | 90 |
|
|
2023
Q1 | $1.13M | Hold |
10,665
| – | – | 0.2% | 93 |
|
|
2022
Q4 | $1.18M | Hold |
10,665
| – | – | 0.23% | 84 |
|
|
2022
Q3 | $918K | Buy |
10,665
+415
| +4% | +$37K | 0.2% | 91 |
|
|
2022
Q2 | $934K | Hold |
10,250
| – | – | 0.19% | 96 |
|
|
2022
Q1 | $841K | Hold |
10,250
| – | – | 0.15% | 104 |
|
|
2021
Q4 | $786K | Sell |
10,250
-600
| -6% | -$47.8K | 0.14% | 108 |
|
|
2021
Q3 | $864K | Hold |
10,850
| – | – | 0.17% | 105 |
|
|
2021
Q2 | $844K | Sell |
10,850
-521
| -5% | -$38.8K | 0.17% | 100 |
|
|
2021
Q1 | $836K | Buy |
11,371
+105
| +0.9% | +$7.75K | 0.18% | 98 |
|
|
2020
Q4 | $879K | Buy |
11,266
+84
| +0.8% | +$6.42K | 0.21% | 91 |
|
|
2020
Q3 | $885K | Buy |
11,182
+209
| +2% | +$16.4K | 0.25% | 85 |
|
|
2020
Q2 | $810K | Hold |
10,973
| – | – | 0.24% | 94 |
|
|
2020
Q1 | $806K | Buy |
10,973
+4,266
| +64% | +$335K | 0.29% | 76 |
|
|
2019
Q4 | $582K | Sell |
6,707
-14,693
| -69% | -$1.21M | 0.16% | 102 |
|
|
2019
Q3 | $1.72M | Hold |
21,400
| – | – | 0.46% | 63 |
|
|
2019
Q2 | $1.71M | Hold |
21,400
| – | – | 0.45% | 62 |
|
|
2019
Q1 | $1.7M | Sell |
21,400
-2,009
| -9% | -$150K | 0.47% | 63 |
|
|
2018
Q4 | $1.71M | Sell |
23,409
-315
| -1% | -$22.2K | 0.52% | 52 |
|
|
2018
Q3 | $1.61M | Sell |
23,724
-5,908
| -20% | -$376K | 0.41% | 72 |
|
|
2018
Q2 | $1.72M | Sell |
29,632
-413
| -1% | -$23.3K | 0.45% | 70 |
|
|
2018
Q1 | $1.56M | Hold |
30,045
| – | – | 0.41% | 71 |
|
|
2017
Q4 | $1.61M | Sell |
30,045
-868
| -3% | -$48.1K | 0.41% | 73 |
|
|
2017
Q3 | $1.89M | Sell |
30,913
-468
| -1% | -$28.4K | 0.5% | 61 |
|
|
2017
Q2 | $1.92M | Hold |
31,381
| – | – | 0.53% | 53 |
|
|
2017
Q1 | $1.9M | Sell |
31,381
-165
| -0.5% | -$10K | 0.54% | 50 |
|
|
2016
Q4 | $1.77M | Sell |
31,546
-45
| -0.1% | -$2.63K | 0.52% | 52 |
|
|
2016
Q3 | $1.88M | Buy |
31,591
+367
| +1% | +$21.5K | 0.57% | 52 |
|
|
2016
Q2 | $1.72M | Buy |
31,224
+314
| +1% | +$16.7K | 0.54% | 54 |
|
|
2016
Q1 | $1.56M | Buy |
30,910
+680
| +2% | +$33.3K | 0.52% | 56 |
|
|
2015
Q4 | $1.52M | Hold |
30,230
| – | – | 0.52% | 54 |
|
|
2015
Q3 | $1.43M | Sell |
30,230
-314
| -1% | -$16.7K | 0.51% | 59 |
|
|
2015
Q2 | $1.66M | Sell |
30,544
-105
| -0.3% | -$5.89K | 0.56% | 50 |
|
|
2015
Q1 | $1.68M | Hold |
30,649
| – | – | 0.53% | 49 |
|
|
2014
Q4 | $1.66M | Sell |
30,649
-2,777
| -8% | -$155K | 0.56% | 49 |
|
|
2014
Q3 | $1.89M | Sell |
33,426
-996
| -3% | -$55.9K | 0.65% | 39 |
|
|
2014
Q2 | $1.9M | Sell |
34,422
-1,949
| -5% | -$106K | 0.65% | 41 |
|
|
2014
Q1 | $1.97M | Sell |
36,371
-105
| -0.3% | -$5.44K | 0.68% | 37 |
|
|
2013
Q4 | $1.74M | Sell |
36,476
-157
| -0.4% | -$7.18K | 0.61% | 45 |
|
|
2013
Q3 | $1.66M | Buy |
36,633
+210
| +0.6% | +$9.59K | 0.63% | 43 |
|
|
2013
Q2 | $1.61M | Buy |
+36,423
| New | +$1.63M | 0.64% | 41 |
|
Other funds holding MRK
ECSS
Baker Ellis Asset Management's MRK Position: Q2 2026 in Review
Baker Ellis Asset Management held its Merck (MRK) position steady in Q2 2026 at 14,988 shares worth $1.93M. The position accounts for 0.2% of the portfolio, ranked #88.
Baker Ellis Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.97M in Q1 2014. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Baker Ellis Asset Management held 14,988 shares of Merck worth $1.93M as of Q2 2026.
- Baker Ellis Asset Management left its Merck share count unchanged in Q2 2026.
- Merck made up 0.2% of Baker Ellis Asset Management's portfolio in Q2 2026, its #88 holding.
- Baker Ellis Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Baker Ellis Asset Management's Merck position peaked at $1.97M in Q1 2014.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.